Business Wire

Terraformation Officially Launches Terraware, Closing the Technology Gap in Global Reforestation

Share

Today, Terraformation, a native forest restoration company dedicated to addressing climate change, announced the official launch of Terraware, its global forestry management platform. Built by foresters, for foresters, the software enables forestry teams worldwide to manage all stages of restoration projects—from site planning to seed collection, nursery management, carbon tracking, and planting. The robust platform streamlines data collection and reporting, and bridges the gap between remote sensing and ground data, providing a clearer picture of forest health and progress.

“Large-scale reforestation is labor-intensive, and there has been a noticeable technology gap within the forestry industry. Terraware translates science-backed methods for managing and measuring forestry projects into simple, accessible data and digestible action steps for forestry organizations,” said Yishan Wong, Founder and CEO of Terraformation. “This type of technology is a mission-critical component in the global effort to combat climate change through reforestation, and that is why we made a conscious decision to make it available to everyone.”

Restoring a biodiverse forest involves a complex and time-consuming set of tasks: mapping planting areas, sourcing native seeds, managing nursery operations, tracking planting progress, adapting to changing conditions, and more. Through years of extensive research and real-world forestry project experience, Terraformation identified the need for advanced, user-friendly tools to support the entire reforestation process. What began as a tool for seed collection has evolved into a comprehensive forest management platform that can be leveraged by forestry teams as well as project investors and funders.

Terraware was developed and tested with key partners, and over 300 organizations in 60 countries have registered to use Terraware. Key software features include:

  • Project Management Tools for Forest Restoration Teams: Terraware streamlines project planning, monitoring, and reporting processes, reducing administrative burdens and freeing up resources to focus on fieldwork.
  • Seamless Reporting for Donors and Investors: With tools like automated reporting templates and a funder portal, Terraware ensures that all stakeholders have access to accurate, up-to-date information on project status, fostering trust and transparency, and enabling better decision-making. (Available to Terraformation’s Accelerator partners)
  • Survival Monitoring for Seed Bank and Nursery Managers: By providing detailed tracking and monitoring of plants as they move from seed germination to seedlings and eventually plants in the field, Terraware helps foresters optimize every part of their project, identify problems earlier, reduce waste, and lower costs.
  • Real-time Tracking for Field Technicians: Terraware’s ability to track data from seed to forest maturity allows foresters to make informed decisions and adapt management practices in response to on-the-ground realities, leading to more resilient forests and higher project success rates.

“The insights we gain from Terraware are invaluable. It not only simplifies our project tracking but has also empowered our team to make informed decisions, ensuring our restoration projects remain on course to meet their goals.” — Benson Tilya, Seed Bank Analyst and Conservation Manager, Saving Africa’s Nature (SANA)

Terraware is currently in use by forestry and conservation organizations, including participants in Terraformation’s Seed to Carbon Forest Accelerator, a biodiversity-focused, carbon-funded program that supports forestry teams with the skills, tools, and funding access to create investable projects. Terraformation recently welcomed seven teams from Brazil, Colombia, Ghana, Kenya, and Tanzania to its fourth cohort and is currently accepting applications for its next cohort of forestry teams.

Through Terraware, investors and corporate sustainability teams supporting Terraformation’s Accelerator projects have access to robust and transparent data, offering detailed real-time insights from the start of a high-quality, carbon-certified project, helping them feel confident in the success of their investments. The software provides plant tracking solutions that match the latest carbon methodologies from carbon certification bodies like Verra.

Terraware is accessible at https://terraware.io and as a mobile app (iOS and Android), with offline data collection options for essential features like seed collecting and plant tracking.

To learn more about Terraformation and its industry-leading software, visit: https://terraformation.com/terraware

About Terraformation

Terraformation is a native forest restoration company dedicated to addressing climate change by rapidly expanding large-scale biodiverse forest projects. Our portfolio of high-quality projects is designed to restore native forests that will remove high quantities of carbon dioxide from the atmosphere, renew ecosystems, enhance biodiversity and climate resilience, and produce multiple community benefits. Our project teams have planted over one million biodiverse and native trees, stored 131 million seeds, supported 19 forestry projects, and created over 700 jobs through reforestation efforts worldwide.

Our multifaceted approach equips local forestry teams with training, technology, and access to capital to ensure transparency and long-term success. By supporting our forestry projects, corporations can directly address climate change and offset carbon emissions while transforming ecosystems and communities.

Founded in 2020, Terraformation brings together experts in forest science, carbon markets, operations, and business development to offer a unique approach to accelerate scalable and effective climate solutions.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240918844939/en/

Contacts

Media Contact:
Jacob Westfall
Terraformation@FinnPartners.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Vertex Announces US FDA Approval of ALYFTREK ™ , a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis20.12.2024 21:46:00 CET | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor), a once-daily next-in-class triple combination cystic fibrosis transmembrane conductance regulator (CFTR) modulator for the treatment of cystic fibrosis (CF) in people 6 years and older who have at least one F508del mutation or another mutation in the CFTR gene that is responsive to ALYFTREK. See below for Important Safety Information, including a Boxed Warning. “ALYFTREK is our fifth CFTR modulator to secure FDA approval and represents another significant milestone in our journey to serially innovate and to improve the lives of people living with cystic fibrosis,” said Reshma Kewalramani, M.D., Chief Executive Officer and President of Vertex. “Our north star for more than 20 years has been to address the underlying cause of cystic fibrosis, treat more people with this disease, and bring more people to normal le

Vertex Announces U.S. FDA Approval for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Include Additional Non- F508del TRIKAFTA-Responsive Variants20.12.2024 21:35:00 CET | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 2 and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a mutation that is responsive to TRIKAFTA based on clinical and/or in vitro data. In addition, safety information on liver injury and liver failure has been updated from warnings and precautions to a boxed warning. With this approval, 94 additional non-F508delCFTR mutations have been added to the TRIKAFTA label, and approximately 300 additional people with CF in the U.S. are now eligible for a medicine to treat the underlying cause of their disease for the first time. “Since its first approval in 2019, TRIKAFTA has had a transformative impact on tens of thousands of people living with cystic fibrosis,” sai

HSBC Continental Europe Enters Into a Memorandum of Understanding Regarding Potential Sale of HSBC Assurances Vie (France) to Matmut Société d’Assurance Mutuelle20.12.2024 20:32:00 CET | Press Release

Regulatory News: HSBC Continental Europe has signed a Memorandum of Understanding (‘MOU‘) regarding the potential sale of its French life insurance business, HSBC Assurances Vie (France), to Matmut Société d’Assurance Mutuelle (‘Matmut’) (the “Potential Transaction”). HSBC Assurances Vie (France) provides a wide range of life insurance solutions and services, with over 20 billion euros of outstanding assets, net income1 of 77 million euros and a Solvency II ratio of 287% in 2023. As part of the Potential Transaction, HSBC Continental Europe and Matmut would enter into a long-term arrangement for HSBC Global Asset Management (France) to continue to partner with HSBC Assurances Vie (France). HSBC Assurances Vie (France) will continue its existing distribution arrangements. The Potential Transaction would provide customers and employees of HSBC Insurance Life (France) with the opportunity to join one of the leading French mutual insurance groups, which is in full development, and forms pa

SBC Medical Group Co., Ltd. Sells Two Subsidiaries20.12.2024 13:00:00 CET | Press Release

On December 17, 2024, SBC Medical Group Holdings Incorporated (“SBC Medical”, or the “Company”), announced that its subsidiary, SBC Medical Group Co., Ltd. (hereinafter referred to as "SBCMG"), has decided to sell all shares of its subsidiaries, SBC Kijimadaira Resort Co., Ltd. (hereinafter referred to as "Kijimadaira") and Skynet Academy Co., Ltd. (hereinafter referred to as "SNA"), as outlined below. The decision to sell these subsidiaries was made to concentrate SBCMG's management resources on its core medical services business, in line with its strategy of prioritizing and focusing on key business areas. The subsidiaries being sold operate in the following industries: Kijimadaira: Ski resort operations SNA: Flight training operations The shares will be sold to a company wholly owned by Yoshiyuki Aikawa, the CEO of the Company. Since this transaction constitutes a related party transaction, it was deliberated and approved by the Company’s Board of Directors and Audit Committee. To e

Aarhus University: New Global Study Sheds Light on the Learning Crisis: Three Years After COVID-1920.12.2024 13:00:00 CET | Press Release

TIMSS 2023 has revealed an alarming global learning crisis exacerbated by the COVID-19 pandemic. Compared to the long term trend in progress in mathematics and science achievement has not only stalled but reversed when taking school closures into account, with the most vulnerable students facing the steepest losses. Key Findings Global Achievement Decline: A 0.11 standard deviation drop in student performance reflects the pandemic's lasting impact. Disproportionate Impact: Low performers, girls, and language minorities faced losses up to twice the average (0.22 standard deviations), deepening existing inequities. Regional Variations: Countries with prolonged school closures and limited remote learning resources experienced the steepest declines. Why This Matters School closures disrupted the education of over one billion children worldwide, with disadvantaged students suffering the most. “The widening gender gap in STEM fields is particularly troubling,” said Christian Kjeldsen, incomi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye